全文获取类型
收费全文 | 604篇 |
免费 | 113篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 12篇 |
妇产科学 | 5篇 |
基础医学 | 33篇 |
口腔科学 | 9篇 |
临床医学 | 77篇 |
内科学 | 159篇 |
皮肤病学 | 14篇 |
神经病学 | 38篇 |
特种医学 | 204篇 |
外科学 | 59篇 |
综合类 | 11篇 |
预防医学 | 20篇 |
眼科学 | 2篇 |
药学 | 19篇 |
肿瘤学 | 58篇 |
出版年
2023年 | 11篇 |
2021年 | 7篇 |
2020年 | 6篇 |
2019年 | 5篇 |
2018年 | 28篇 |
2017年 | 10篇 |
2016年 | 17篇 |
2015年 | 22篇 |
2014年 | 39篇 |
2013年 | 46篇 |
2012年 | 5篇 |
2011年 | 14篇 |
2010年 | 34篇 |
2009年 | 43篇 |
2008年 | 20篇 |
2007年 | 13篇 |
2006年 | 10篇 |
2005年 | 15篇 |
2004年 | 16篇 |
2003年 | 10篇 |
2002年 | 10篇 |
2001年 | 10篇 |
2000年 | 15篇 |
1999年 | 13篇 |
1998年 | 22篇 |
1997年 | 26篇 |
1996年 | 17篇 |
1995年 | 15篇 |
1994年 | 10篇 |
1993年 | 16篇 |
1992年 | 10篇 |
1991年 | 14篇 |
1990年 | 12篇 |
1989年 | 24篇 |
1988年 | 18篇 |
1987年 | 19篇 |
1986年 | 12篇 |
1985年 | 20篇 |
1984年 | 5篇 |
1983年 | 8篇 |
1982年 | 9篇 |
1981年 | 7篇 |
1980年 | 9篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1976年 | 7篇 |
1975年 | 4篇 |
1971年 | 1篇 |
1961年 | 1篇 |
排序方式: 共有722条查询结果,搜索用时 171 毫秒
1.
Practical management of patients with non-small-cell lung cancer treated with gefitinib. 总被引:7,自引:0,他引:7
Neelam T Shah Mark G Kris William Pao Leslie B Tyson Barbara M Pizzo Murk-Hein Heinemann Leah Ben-Porat Dana L Sachs Robert T Heelan Vincent A Miller 《Journal of clinical oncology》2005,23(1):165-174
PURPOSE: The use of gefitinib, the first drug approved to inhibit the epidermal growth factor receptor tyrosine kinase, is indicated in patients with non-small-cell lung cancer with tumors progressive after chemotherapy. The unique mechanism of action of this agent leads to distinctive patterns of response and toxicity in persons with lung cancer. Many of the principles of management relevant to gefitinib are distinct from those with conventional cytotoxic drugs. To meet this need, we present practical guidelines on the use of gefitinib in patients with non-small-cell lung cancer. METHODS: This article reviews gefitinib's indications, dosing, response phenomena, and patterns of relapse in individuals with radiographic response. RESULTS: We present our recommendations for the management of rash and diarrhea caused by this agent. CONCLUSION: This information can guide practitioners and help them inform their patients about what to expect when they receive gefitinib. 相似文献
2.
3.
4.
5.
6.
7.
8.
9.
J S Heelan S M Opal E Brissette M Donahue 《Diagnostic microbiology and infectious disease》1992,15(1):5-11
After converting from a conventional broth (CB) system to a biphasic (BP) agar-slide blood-culture system (Septi-Chek), our laboratory noted an increase in positive blood cultures in general, and in coagulase-negative staphylococci (CNS) in particular. To investigate these findings, we compared all blood cultures collected over a 21-month period using CB and then BP systems, totaling 28,199 blood cultures. The frequency of positive blood cultures increased from 9.2% to 12.7% (p less than 0.0001), whereas CNS isolation increased from 2.6% to 5.2% (p less than 0.0001). There was no significant change in the incidence of true primary or secondary bacteremia due to CNS (p = 0.9). The isolation of other pathogens, including Staphylococcus aureus, Candida albicans, Bacteroides species, and Gram-negative bacilli increased from 6.5% to 7.1% (p less than 0.05). We estimated the cost of processing 28,000 blood cultures by both CB and BP systems, using positivity rates of 9.2% and 12.7%, respectively, and standards provided by the College of American Pathologists (CAP, 1991) for workload hours of technologist time. We calculated a higher overall cost for the BP system. However, the use of this system eliminated the use of needles and syringes for subculture of bottles showing no growth, thus decreasing the risk of technologist exposure to body fluids. Despite the increased cost and more frequent occurrence of pseudobacteremia, the enhanced sensitivity and increased safety of the BP system justified its use in the prompt identification of patients with true bacteremia. 相似文献
10.
Chest radiographs and chest computed tomography (CT) scans were compared in 203 patients with newly diagnosed Hodgkin disease. The incidence of positive findings was tabulated from six intrathoracic lymph node groups, lung parenchyma, pericardium, pleura, and chest wall. The discordant cases were assessed to determine impact on clinical management. The CT scans provided additional evidence of disease involvement, ranging from 0% to 15% at each of the designated anatomic sites. Treatment was altered in 9.4% of all patients (19 of 203), including 13.8% (nine of 65) of those undergoing radiation therapy alone and 8.2% (ten of 122) of those undergoing combined-modality treatment. We conclude that routine chest CT examinations are valuable in the clinical management of those patients for whom radiation therapy is planned. 相似文献